Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Current therapy of multiple sclerosis].
Headache in multiple sclerosis and autoimmune disorders.
Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab.
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
Pituitary apoplexy presented with optic neuritis.
The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals.
Curcumin protects axons from degeneration in the setting of local neuroinflammation.
[Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
Electrolyte imbalance triggering relapse of inflammatory neuropathy.
Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation.
Histamine H2 receptor signaling x environment interactions determine susceptibility to experimental allergic encephalomyelitis.
The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model.
A case of neuromyelitis optica spectrum disorder presenting with severe orthostatic hypotension.
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.
Female sexual dysfunction in multiple sclerosis: Results of a survey among Dutch urologists and patients.
Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model.
Differentiating white matter lesions in multiple sclerosis and migraine using monoexponential and biexponential diffusion measurements.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
[Anaesthetic management of patient with neurological disease: Focus on regional anaesthesia.]
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
The detection of sensitivity of proprioception by a new clinical test: The dual joint position test.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
[Update on diagnosis and treatment of multiple sclerosis.]
Pages
« first
‹ previous
…
447
448
449
450
451
452
453
454
455
…
next ›
last »